Wei Kang
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 10
- Infectious Diseases top 1%
- Molecular Biology top 1%
- RNA modifications and cancer 30
- Cancer-related gene regulation 21
- Epigenetics and DNA Methylation 19
- RNA Research and Splicing 10
- Oncology top 2%
- Cell Biology top 1%
- Hippo pathway signaling and YAP/TAZ 18
-
- Genetic factors in colorectal cancer 9
- Co-authors
- Jun YuKa‐Fai ToAlfred S.L. ChengJoseph J.�Y. SungTingting HuangChi Chun WongRaymond Wai Ming LungHuarong Chen
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Wei Kang
163 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 2.3k
- Infectious Diseases 1.3k
- Molecular Biology 4.9k
- Oncology 1.5k
- Cell Biology 839
Countries citing papers authored by Wei Kang
This map shows the geographic impact of Wei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Kang more than expected).
Fields of papers citing papers by Wei Kang
This network shows the impact of papers produced by Wei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Kang. The network helps show where Wei Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | The arginine metabolism and its deprivation in cancer therapybreakdown → | 2025 | 17 |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 56 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 48 | |
| 10 | Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma | 2019 | 3 |
| 11 | 2019 | 14 | |
| 12 | 2019 | 68 | |
| 13 | 2018 | 70 | |
| 14 | 2018 | 52 | |
| 15 | 2018 | 84 | |
| 16 | 2018 | 16 | |
| 17 | 2017 | 51 | |
| 18 | 2017 | 32 | |
| 19 | 2013 | 92 | |
| 20 | 2011 | 211 |
About Wei Kang
Wei Kang is a scholar working on Cancer Research, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 169 papers that have together received 8.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (30 papers), Cancer-related molecular mechanisms research (24 papers), Cancer-related gene regulation (21 papers), Epigenetics and DNA Methylation (19 papers), Hippo pathway signaling and YAP/TAZ (18 papers), MicroRNA in disease regulation (10 papers), RNA Research and Splicing (10 papers) and Genetic factors in colorectal cancer (9 papers). The work is most often cited by research in Cancer Research (2.3k citations), Infectious Diseases (1.3k citations) and Molecular Biology (4.9k citations). Wei Kang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jun Yu, Ka‐Fai To, Alfred S.L. Cheng, Joseph J.�Y. Sung, Tingting Huang, Chi Chun Wong, Raymond Wai Ming Lung, Huarong Chen, Joanna H. Tong and Jian Geng. Their work appears in journals such as Oncogene, Gastroenterology, Molecular Cancer, Frontiers in Microbiology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.